A short term quality control tool for biodegradable microspheres.

Area of Science:

• Pharmaceutical Sciences
• Materials Science
• Biotechnology

Background:

• Evaluating biodegradable microsphere performance is challenging due to slow polymer degradation, leading to extended study times and costs.
• In vivo and in vitro experiments are traditionally used but can be resource-intensive.
• Quality control (QC) for clinical and commercial batches requires efficient and reliable methods.

Purpose of the Study:

• To develop an accelerated in vitro release testing methodology for biodegradable microspheres.
• To establish this method as a discriminatory quality control (QC) technique for batch release.
• To assess the method's ability to predict product performance and differentiate process variants.

Main Methods:

• Manufactured three batches of Leuprolide poly(lactic-co-glycolic acid) (PLGA) microspheres with varying morphology using solvent extraction/evaporation.
• Performed accelerated in vitro release, polymer degradation, and hydration tests at 55°C.
• Analyzed in vitro peptide release using the modified Weibull equation (MWE).

Main Results:

• Demonstrated excellent reproducibility within and between microsphere batches at 55°C.
• Confirmed the predictability of accelerated experiments, showing good correlation with product performance.
• Successfully discriminated between microsphere batches with varying morphology, validating its discriminatory power.

Conclusions:

• The accelerated in vitro release testing methodology is a suitable QC tool for biodegradable microspheres.
• The method effectively distinguishes product or process variants in clinical or commercial batches.
• The modified Weibull equation enhances the discriminatory power of the accelerated testing at 55°C.